Modern Management of MPNs: Recent Advances and Future Directions in ET, PV, and MF

Download All
Review the latest data and expert guidance to enhance your treatment of essential thrombocythemia, polycythemia vera, and myelofibrosis! This comprehensive program features focused commentaries, an expert analysis module, and downloadable slides.
Rami S. Komrokji, MD
Brady L. Stein, MD, MHS
Srdan Verstovsek, MD, PhD


How will new and forthcoming clinical data change the management of essential thrombocythemia, polycythemia vera, and myelofibrosis? Here’s my take.

Srdan Verstovsek, MD, PhD Released: February 25, 2019

Read how I approach the most pressing clinical issues in diagnosis and management of polycythemia vera, essential thrombocythemia, and myelofibrosis.

Rami S. Komrokji, MD Released: April 9, 2019

In this commentary, I review key data from ASCO and EHA 2019 on investigational treatments for patients with myelofibrosis or polycythemia vera.

Brady L. Stein, MD, MHS Released: July 8, 2019
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Celgene Corporation
Incyte Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings